These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3400649)

  • 1. Multidisciplinary cost-containment program promoting less frequent administration of injectable mezlocillin.
    Briceland LL; Nightingale CH; Quintiliani R; Cooper BW
    Am J Hosp Pharm; 1988 May; 45(5):1082-5. PubMed ID: 3400649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidisciplinary cost-containment program promoting oral metronidazole for treatment of antibiotic-associated colitis.
    Briceland LL; Quintiliani R; Nightingale CH
    Am J Hosp Pharm; 1988 Jan; 45(1):122-5. PubMed ID: 3348224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a pharmacy-based cost-containment program on cimetidine costs and use.
    Kong KM; Johnson WF; Anderson PO; Sato LA; Simonian RI
    Am J Hosp Pharm; 1987 Sep; 44(9):2068-73. PubMed ID: 3674045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidisciplinary program for promoting single prophylactic doses of cefazolin in obstetrical and gynecological surgical procedures.
    Smith KS; Quercia RA; Chow MS; Nightingale CH; Quintiliani R; Millerick JD
    Am J Hosp Pharm; 1988 Jun; 45(6):1338-42. PubMed ID: 3414702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procedural compliance and clinical outcome associated with therapeutic interchange of extended-spectrum penicillins.
    Martin LA; Watkins JB; Greene SA; Haddow AD; Gerecht WB; Powell CW
    Am J Hosp Pharm; 1990 Jul; 47(7):1551-4. PubMed ID: 2368746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of pharmacodynamic concepts in developing a cost-effective dosing method for piperacillin.
    Quintiliani R; Nightingale CH; Sullivan MC
    Clin Ther; 1993; 15 Suppl A():44-9. PubMed ID: 8513461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimizing i.v. admixture waste in a 70-bed hospital.
    Tullio CJ
    Hosp Pharm; 1987 Oct; 22(10):994, 997, 1001. PubMed ID: 10284567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interdisciplinary committee on infusion-control devices: containing related-product costs.
    Donnelly EB; Witte KW; Eck TA; LaPlume G
    Am J Hosp Pharm; 1988 Mar; 45(3):595-600. PubMed ID: 3369462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of a once-daily aminoglycoside program in a large community-teaching hospital.
    Nicolau DP; Belliveau PP; Nightingale CH; Quintiliani R; Freeman CD
    Hosp Pharm; 1995 Aug; 30(8):674-6, 679-80. PubMed ID: 10144645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved reporting of adverse drug reactions.
    Kimelblatt BJ; Young SH; Heywood PM; Mandala AR; Gendelman S; Mehl B
    Am J Hosp Pharm; 1988 May; 45(5):1086-9. PubMed ID: 3400650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of staff pharmacists to reduce the inappropriate use of parenteral histamine-2 antagonist therapy.
    Caldwell RD; Davis SK
    Hosp Pharm; 1987 Dec; 22(12):1205-9. PubMed ID: 10285375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategic planning for clinical services: St. Joseph Hospital and Health Care Center.
    Linggi A; Pelham LD
    Am J Hosp Pharm; 1986 Sep; 43(9):2164-8. PubMed ID: 3532777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Department of pharmacy-initiated program for streamlining empirical antibiotic therapy.
    Pastel DA; Chang S; Nessim S; Shane R; Morgan MA
    Hosp Pharm; 1992 Jul; 27(7):596-603, 614. PubMed ID: 10119188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applying for a certificate of need for unit dose and i.v. admixture services in a Connecticut hospital.
    Gousse GC; Nightingale CH; Dionne GP; Meehan J
    Am J Hosp Pharm; 1984 Oct; 41(10):2029-32. PubMed ID: 6496491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development, implementation, and results of a successful multidisciplinary adverse drug reaction reporting program in a university teaching hospital.
    Murphy BM; Frigo LC
    Hosp Pharm; 1993 Dec; 28(12):1199-204, 1240. PubMed ID: 10130617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Audit mechanism for hospital drug distribution.
    Broekemeier RL; Brewer PE; Johnson MK
    Am J Hosp Pharm; 1980 Jan; 37(1):85-8. PubMed ID: 7189096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of drug distribution costs for controlled versus noncontrolled oral analgesics.
    Reynolds RC; Ploetz P; Thielke TS
    Am J Hosp Pharm; 1984 Aug; 41(8):1558-63. PubMed ID: 6475974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacy-based distribution system for enteral nutrition products.
    Craig SA; Paulson MF
    Am J Hosp Pharm; 1985 Dec; 42(12):2691-4. PubMed ID: 3936356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategy for developing a safe and cost-effective H2-receptor antagonist program.
    Quercia RA; Chow MS; Jay GT; Quintiliani R
    Hosp Formul; 1991 Nov; 26 Suppl D():20-4. PubMed ID: 10136561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IV additive program saves Montreal hospital $300,000.
    Torchinsky A
    Health Care (Don Mills); 1986 Jun; 28(5):25-8. PubMed ID: 10277322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.